COVID-19

FTD SARS-CoV-2 Assay

For the specific detection of the coronavirus causing COVID-19

The FTD SARS-CoV-2 Assay1, which is intended for the initial diagnosis of the infection of the SARS-CoV-2 virus, is complemented by the portfolio of A1 Life Sciences‘ Diagnovital kits. Diagnovital kits are designed to detect and identify SARS-CoV-2 mutations and complement Siemens Healthineers FTD SARS-CoV-2 Assay for diagnosis of COVID-19 infection. Identifying mutations and variants helps not only epidemiologists, but also helps support informed decision-making about public health actions to control spread. Given the certainty that further mutations and variants will emerge, along with the uncertainty as to whether these variants will become VOCs, the testing will be flexible and highly adaptable. With single-mutation formatted assays, like those in the A1 Life Sciences’ Diagnovital portfolio, laboratories can select from individual assays to create their appropriate testing scheme based on mutations prevalent in their region. Together with the dual-target design of the FTD SARS-CoV-2 Assay, laboratories can select from individual assays to create their appropriate testing scheme based on mutations prevalent in their region.

Uso Clínico

In late 2019, China notified the World Health Organization (WHO) of a novel strain of coronavirus. This virus, now named SARS-CoV-2, targets the epithelial cells of the respiratory tract and causes infection that can lead to Coronavirus disease 2019 (COVID-19). Siemens Healthineers new molecular assay uses real-time PCR to detect RNA from this virus.

Variant key visual image

As part of our ongoing Global Surveillance Program, the FTD SARS-CoV-2 Assay1 has been shown to detect emergent SARS-CoV-2 variants.

View the results of in silico analysis to learn more! 

Explore our dual-target design for the detection of SARS-CoV-2

Características e Benefícios

  • Kit comprised of a single-well dual target assay for the specific detection of SARS-CoV-2 (COVID-19)
  • Designed for high sensitivity, specificity, and inclusivity
  • Covers highly conserved regions within ORF1ab and N gene
  • Uses the same assay setup protocol and thermal-cycling profile as all FTD respiratory disease kits

1